Research programme: syringin - China Botanic Pharmaceutical

Drug Profile

Research programme: syringin - China Botanic Pharmaceutical

Alternative Names: Siberian ginseng (Acanthopanax) lyophilised syringin powder - China Botanic Pharmaceutical; Syringin freeze-dried Acanthopanax powder - China Botanic Pharmaceutical

Latest Information Update: 20 Mar 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Renhuang Pharmaceuticals
  • Developer China Botanic Pharmaceutical
  • Class Alternative medicine; Glucosides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Fatigue; Major depressive disorder

Most Recent Events

  • 20 Mar 2012 Preclinical development is ongoing in China
  • 29 Nov 2010 Renhuang Pharmaceutical is now called China Botanic Pharmaceutical
  • 24 Jan 2008 Preclinical trials in Fatigue in China (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top